CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 119 filers reported holding CARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,229,610 | -40.5% | 3,708,101 | +0.2% | 0.00% | – |
Q2 2023 | $10,476,570 | -71.9% | 3,701,968 | -51.3% | 0.00% | -100.0% |
Q1 2023 | $37,329,175 | -55.1% | 7,602,683 | -1.7% | 0.00% | -66.7% |
Q4 2022 | $83,049,521 | +17.0% | 7,732,730 | +2.0% | 0.00% | +50.0% |
Q3 2022 | $70,972,000 | +5.7% | 7,582,294 | +3.1% | 0.00% | 0.0% |
Q2 2022 | $67,131,000 | -23.1% | 7,352,787 | +2.3% | 0.00% | 0.0% |
Q1 2022 | $87,322,000 | -0.4% | 7,187,124 | -0.2% | 0.00% | 0.0% |
Q4 2021 | $87,683,000 | -20.1% | 7,199,126 | +1.3% | 0.00% | -33.3% |
Q3 2021 | $109,778,000 | +5.4% | 7,105,389 | -2.6% | 0.00% | 0.0% |
Q2 2021 | $104,115,000 | +30.1% | 7,296,068 | +97.9% | 0.00% | +50.0% |
Q1 2021 | $80,042,000 | +45.7% | 3,686,965 | +1.5% | 0.00% | 0.0% |
Q4 2020 | $54,955,000 | +16.9% | 3,632,266 | -1.7% | 0.00% | 0.0% |
Q3 2020 | $47,017,000 | -27.1% | 3,694,949 | -2.0% | 0.00% | -33.3% |
Q2 2020 | $64,490,000 | +39.6% | 3,771,345 | +7.8% | 0.00% | +50.0% |
Q1 2020 | $46,212,000 | -19.1% | 3,498,244 | -1.4% | 0.00% | 0.0% |
Q4 2019 | $57,132,000 | -11.9% | 3,546,310 | -0.1% | 0.00% | -33.3% |
Q3 2019 | $64,878,000 | +5.3% | 3,549,152 | +23.9% | 0.00% | 0.0% |
Q2 2019 | $61,587,000 | +13.5% | 2,864,551 | +3.6% | 0.00% | +50.0% |
Q1 2019 | $54,276,000 | +49.1% | 2,766,310 | -1.2% | 0.00% | 0.0% |
Q4 2018 | $36,407,000 | -44.9% | 2,800,605 | +1.5% | 0.00% | -33.3% |
Q3 2018 | $66,055,000 | +53.9% | 2,758,118 | +23.1% | 0.00% | +50.0% |
Q2 2018 | $42,920,000 | +60.5% | 2,241,248 | +3.7% | 0.00% | +100.0% |
Q1 2018 | $26,745,000 | -1.0% | 2,160,406 | -2.1% | 0.00% | 0.0% |
Q4 2017 | $27,018,000 | +12.3% | 2,207,407 | +25.6% | 0.00% | 0.0% |
Q3 2017 | $24,068,000 | -5.0% | 1,758,073 | +6.8% | 0.00% | 0.0% |
Q2 2017 | $25,345,000 | -2.4% | 1,646,847 | +16.6% | 0.00% | 0.0% |
Q1 2017 | $25,968,000 | +66484.6% | 1,412,092 | +33585.4% | 0.00% | – |
Q4 2016 | $39,000 | +18.2% | 4,192 | +6.4% | 0.00% | – |
Q3 2016 | $33,000 | +73.7% | 3,938 | 0.0% | 0.00% | – |
Q2 2016 | $19,000 | +216.7% | 3,938 | +305.6% | 0.00% | – |
Q1 2016 | $6,000 | – | 971 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |